Sandra Coufal

Dr. Coufal brings over 30 years of experience as a physician and successful entrepreneur working with companies in medicine, chemistry, biotechnology, digital technology, and material sciences to BioAesthetics. Most recently, she co-founded and managed Sibling Capital Ventures and Sibling Capital, founded Relypsa’s and Ilypsa’s Scientific Advisory Boards, and co-founded and serves as Director on the Management Board of Tricida, Inc. (NASDAQ: TCDA). Since 2001, Dr. Coufal served as the Biomedical Advisor for the Genomics Institute of the Novartis Research Foundation. Previously, Dr. Coufal was Head of the Division of Internal Medicine at the Torrey Pines site of Scripps Clinic in La Jolla, CA, where she also sat on the Board of Scripps Green Hospital as the Representative-at-Large. Concurrently, she served as Associate Faculty in the Division of Internal Medicine for UCSD. Dr. Coufal received her medical degree from the University of Texas Southwestern Medical School at Dallas. She also completed an internship and residency in Internal Medicine at the University of Texas Southwestern Medical School at Dallas under Chairman Dr. Daniel Foster. She received her Bachelor of Science undergraduate degree from the University of Notre Dame and was designated a Notre Dame Scholar.